Genetic tests

Genetic testing involves the analysis of 25 cancer-related genes and is performed to assess colorectal cancer risk.

Genetic testing includes analysis of 25 cancer-related genes to assess the risk of developing breast cancer and ovarian cancer.

Genetic testing involves detecting a specific variant of the FTO gene, which affects fat accumulation, in order to identify a predisposition to obesity.

Genetic testing involves the detection of mutations in three genes, PRSS1, SPINK1 and CFTR, associated with an inherited susceptibility to pancreatitis and is used to diagnose hereditary pancreatitis.

Genetic testing involves the detection of mutations in three genes, PRSS1, SPINK1, and CFTR, that are associated with congenital susceptibility to pancreatitis in the rosier version, and is used to diagnose hereditary pancreatitis.

Genetic testing involves detecting a gene variant in one of the coagulation factors, R2 of factor V, associated with increased blood clotting, and allows the risk of venous thrombosis to be assessed.

Genetic testing for hereditary deafness (DFNB1) by analyzing the complete coding sequence of the GJB2 gene allows identification of genetic causes of hearing loss.

The molecular test analyzes the entire coding region of the ATP7B gene for mutations, allowing for a complete and detailed genetic diagnosis of Wilson's disease, a rare genetic disorder associated with excessive copper accumulation in the body.

The molecular test detects the listed most common mutations in the ATP7B gene, as well as other mutations in an area of the gene called exon 8, enabling rapid confirmation of Wilson's disease, a rare genetic disease.